We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
U.S. healthcare has been one of the most-notable sectors to register gains among the broader S&P 500 sectors, thanks to increased national spending on healthcare, stable cash inflow and implementation of ground-breaking new technologies in the sector.
The Health Care Select Sector SPDR (XLV) has increased 8.5% on an annualized basis, ahead of sectors such as communication services, energy and industrials. Therefore, it could be prudent to invest in a few healthcare mutual funds at this point.
U.S. Healthcare Spending to Grow
According to a U.S. Centers for Medicare and Medicaid Services (CMS) report, national health spending is forecast to increase at an average rate of 5.5% on an annualized basis during 2018-2027 to reach about $6 trillion by 2027.
The federal agency also stated that crucial economic and demographic factors that are fundamental to the sector will lead to the sector’s growth during the forecast period.
This projected growth could mean that healthcare would become one of the most lucrative sectors for investments ahead.
Notable New Jobs in Healthcare
The latest report by the Bureau of Labor Statistics, which provides details of the total nonfarm payrolls in March, registered impressive new job additions in the healthcare sector.
The sector added 49,000 new jobs in March and 398,000 over the past year. Employment rose in ambulatory healthcare services, hospitals and nursing and residential care facilities by 27,000, 14,000 and 9,000, respectively.
What is Boosting the U.S. Healthcare Sector?
The U.S. healthcare sector is majorly boosted by the companies’ distinct profit margins and steady cash flows.
In addition, continued research and foreign investments in U.S. biotechnology, implementation and usage of new technological equipment in the sector are also prominent reasons for the sector’s growth.
Finally, the rise in demand for drugs to treat rare diseases and sustain the aging population is also boosting the sector.
Our Choices
Given the encouraging factors propelling the healthcare sector, here are three mutual funds from the sector you could consider investing in. We have selected funds that carry a Zacks Mutual Fund Rank #1 (Strong Buy). Moreover, these funds have encouraging three and five-year returns. Additionally, the minimum initial investment is within $5,000.
We expect these funds to outperform their peers in the future. Remember, the goal of the Zacks Mutual Fund Rank is to guide investors to identify potential winners and losers. Unlike most of the fund-rating systems, the Zacks Mutual Fund Rank is not just focused on past performance, but also on the likely future success of the fund.
The question here is: why should investors consider mutual funds? Reduced transaction costs and diversification of portfolio without several commission charges that are associated with stock purchases are primarily why one should be parking money in mutual funds (read more: Mutual Funds: Advantages, Disadvantages, and How They Make Investors Money).
Eaton Vance Worldwide Health Sciences Fund Class A (ETHSX - Free Report) aims for long-term capital appreciation. The fund invests in a diversified portfolio that constitutes health sciences companies. The fund usually invests the majority of its assets in securities of companies that are engaged in the development, production or distribution of healthcare products, medical equipment and supplies.
This Zacks sector – Health product has a history of positive total returns for more than 10 years. To see how this fund performed compared in its category, and other 1 and 2 Ranked Mutual Funds, please click here.
ETHSX has an annual expense ratio of 1.00%, which is below the category average of 1.26%. The fund has three and five-year returns of 9.5% and 8.5%, respectively. The minimum initial investment for the fund is $1000.
Fidelity Select Biotechnology Portfolio (FBIOX - Free Report) fundaims for capital growth. The fund mostly invests in common stocks of companies. FBIOX primarily invests the majority of its net assets in securities of companies engaged in the research, development, manufacture, and distribution of biotechnological products and services. The non-diversified fund invests in both U.S. and non-U.S. issuers alike.
This Zacks sector – Health product has a history of positive total returns for more than 10 years. To see how this fund performed compared in its category, and other 1 and 2 Ranked Mutual Funds, please click here.
FBIOX has an annual expense ratio of 0.74%, which is below the category average of 1.26%. The fund has three and five-year returns of 13.5% and 8.4%, respectively. The minimum initial investment for the fund is $2500.
Invesco Health Care Fund Investor Class (GTHIX - Free Report) seeks long-term capital appreciation. The fund invests most of its net assets in securities of companies engaged in healthcare-related industries. The fund mostly invests in equity securities, depositary receipts and securities convertible into equity securities.
This Zacks sector – Health product has a history of positive total returns for more than 10 years. To see how this fund performed compared in its category, and other 1 and 2 Ranked Mutual Funds, please click here.
GTHIXhas an annual expense ratio of 1.10%, which is below the category average of 1.26%. The fund has three and five-year returns of 9.6% and 6.4%, respectively. The minimum initial investment for the fund is $1000.
Want key mutual fund info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing mutual funds, each week. Get it free >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Buy These 3 Stunning Healthcare Mutual Funds
U.S. healthcare has been one of the most-notable sectors to register gains among the broader S&P 500 sectors, thanks to increased national spending on healthcare, stable cash inflow and implementation of ground-breaking new technologies in the sector.
The Health Care Select Sector SPDR (XLV) has increased 8.5% on an annualized basis, ahead of sectors such as communication services, energy and industrials. Therefore, it could be prudent to invest in a few healthcare mutual funds at this point.
U.S. Healthcare Spending to Grow
According to a U.S. Centers for Medicare and Medicaid Services (CMS) report, national health spending is forecast to increase at an average rate of 5.5% on an annualized basis during 2018-2027 to reach about $6 trillion by 2027.
The federal agency also stated that crucial economic and demographic factors that are fundamental to the sector will lead to the sector’s growth during the forecast period.
This projected growth could mean that healthcare would become one of the most lucrative sectors for investments ahead.
Notable New Jobs in Healthcare
The latest report by the Bureau of Labor Statistics, which provides details of the total nonfarm payrolls in March, registered impressive new job additions in the healthcare sector.
The sector added 49,000 new jobs in March and 398,000 over the past year. Employment rose in ambulatory healthcare services, hospitals and nursing and residential care facilities by 27,000, 14,000 and 9,000, respectively.
What is Boosting the U.S. Healthcare Sector?
The U.S. healthcare sector is majorly boosted by the companies’ distinct profit margins and steady cash flows.
In addition, continued research and foreign investments in U.S. biotechnology, implementation and usage of new technological equipment in the sector are also prominent reasons for the sector’s growth.
Finally, the rise in demand for drugs to treat rare diseases and sustain the aging population is also boosting the sector.
Our Choices
Given the encouraging factors propelling the healthcare sector, here are three mutual funds from the sector you could consider investing in. We have selected funds that carry a Zacks Mutual Fund Rank #1 (Strong Buy). Moreover, these funds have encouraging three and five-year returns. Additionally, the minimum initial investment is within $5,000.
We expect these funds to outperform their peers in the future. Remember, the goal of the Zacks Mutual Fund Rank is to guide investors to identify potential winners and losers. Unlike most of the fund-rating systems, the Zacks Mutual Fund Rank is not just focused on past performance, but also on the likely future success of the fund.
The question here is: why should investors consider mutual funds? Reduced transaction costs and diversification of portfolio without several commission charges that are associated with stock purchases are primarily why one should be parking money in mutual funds (read more: Mutual Funds: Advantages, Disadvantages, and How They Make Investors Money).
Eaton Vance Worldwide Health Sciences Fund Class A (ETHSX - Free Report) aims for long-term capital appreciation. The fund invests in a diversified portfolio that constitutes health sciences companies. The fund usually invests the majority of its assets in securities of companies that are engaged in the development, production or distribution of healthcare products, medical equipment and supplies.
This Zacks sector – Health product has a history of positive total returns for more than 10 years. To see how this fund performed compared in its category, and other 1 and 2 Ranked Mutual Funds, please click here.
ETHSX has an annual expense ratio of 1.00%, which is below the category average of 1.26%. The fund has three and five-year returns of 9.5% and 8.5%, respectively. The minimum initial investment for the fund is $1000.
Fidelity Select Biotechnology Portfolio (FBIOX - Free Report) fundaims for capital growth. The fund mostly invests in common stocks of companies. FBIOX primarily invests the majority of its net assets in securities of companies engaged in the research, development, manufacture, and distribution of biotechnological products and services. The non-diversified fund invests in both U.S. and non-U.S. issuers alike.
This Zacks sector – Health product has a history of positive total returns for more than 10 years. To see how this fund performed compared in its category, and other 1 and 2 Ranked Mutual Funds, please click here.
FBIOX has an annual expense ratio of 0.74%, which is below the category average of 1.26%. The fund has three and five-year returns of 13.5% and 8.4%, respectively. The minimum initial investment for the fund is $2500.
Invesco Health Care Fund Investor Class (GTHIX - Free Report) seeks long-term capital appreciation. The fund invests most of its net assets in securities of companies engaged in healthcare-related industries. The fund mostly invests in equity securities, depositary receipts and securities convertible into equity securities.
This Zacks sector – Health product has a history of positive total returns for more than 10 years. To see how this fund performed compared in its category, and other 1 and 2 Ranked Mutual Funds, please click here.
GTHIX has an annual expense ratio of 1.10%, which is below the category average of 1.26%. The fund has three and five-year returns of 9.6% and 6.4%, respectively. The minimum initial investment for the fund is $1000.
Want key mutual fund info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing mutual funds, each week. Get it free >>